December 17, 2024 00:56 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GRAP 4 restrictions reimposed in Delhi as air quality dips to 'severe' category | 39 ministers included in Devendra Fadnavis-led Maharashtra cabinet | People who raise questions on EVMs should show how they can be hacked: TMC trashes Congress claims | Bangladesh likely to hold national polls in late 2025 or early 2026, says Yunus in Victory Day speech | Constitution stood test of time: Nirmala Sitharaman in Rajya Sabha | PM Museum requests Rahul Gandhi to return Pandit Nehru's historical letters | Indian tabla maestro Zakir Hussain dies at 73 in San Francisco, confirms family | Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested
Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Feb 07, 2020, at 02:39 pm

Mumbai/UNI Pharma Major Dr Reddy's Laboratories on Friday announced the US launch of Trientine Hydrochloride Capsules a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the US Food and Drug Administration (USFDA).